EASY BIO,Inc. (353810.KQ)

KRW 4570.0

(0.44%)

Total Debt Summary of EASY BIO,Inc.

EASY BIO,Inc.'s latest annual total debt in 2023 was 82.27 Billion KRW , up 0.05% from previous year.
EASY BIO,Inc.'s latest quarterly total debt in 2024 Q1 was 128.9 Billion KRW , up 56.67% from previous quarter.
EASY BIO,Inc. reported annual total debt of 82.23 Billion KRW in 2022, up 60.55% from previous year.
EASY BIO,Inc. reported annual total debt of 51.21 Billion KRW in 2021, up 37.54% from previous year.
EASY BIO,Inc. reported quarterly total debt of 215.58 Billion KRW for 2024 Q2, up 67.24% from previous quarter.
EASY BIO,Inc. reported quarterly total debt of 77.89 Billion KRW for 2023 Q2, down -13.93% from previous quarter.

Annual Total Debt Chart of EASY BIO,Inc. (2023 - 2020)

Historical Annual Total Debt of EASY BIO,Inc. (2023 - 2020)

Year	Total Debt	Total Debt Growth
2023	82.27 Billion KRW	0.05%
2022	82.23 Billion KRW	60.55%
2021	51.21 Billion KRW	37.54%
2020	37.23 Billion KRW	0.0%

Year	Total Debt	Total Debt Growth
2024 Q1	128.9 Billion KRW	56.67%
2024 Q2	215.58 Billion KRW	67.24%
2023 Q2	77.89 Billion KRW	-13.93%
2023 FY	82.27 Billion KRW	0.05%
2023 Q4	82.27 Billion KRW	-13.89%
2023 Q3	95.54 Billion KRW	22.66%
2023 Q1	90.5 Billion KRW	10.06%
2022 Q1	54.16 Billion KRW	5.75%
2022 FY	82.23 Billion KRW	60.55%
2022 Q4	82.23 Billion KRW	-26.52%
2022 Q3	111.91 Billion KRW	31.7%
2022 Q2	84.97 Billion KRW	56.89%
2021 Q4	51.21 Billion KRW	-19.07%
2021 Q3	63.28 Billion KRW	28.61%
2021 Q2	49.2 Billion KRW	15.38%
2021 FY	51.21 Billion KRW	37.54%
2021 Q1	42.64 Billion KRW	14.52%
2020 Q3	33.06 Billion KRW	-2.4%
2020 Q4	37.23 Billion KRW	12.62%
2020 Q2	33.87 Billion KRW	0.0%
2020 FY	37.23 Billion KRW	0.0%

Peer Total Debt Comparison of EASY BIO,Inc.

Name	Total Debt	Total Debt Difference
HLB Co., Ltd.	62.7 Billion KRW	-31.213%
iNtRON Biotechnology, Inc.	402.9 Million KRW	-20320.947%
BINEX Co., Ltd.	53.5 Billion KRW	-53.77%
Bioneer Corporation	44.63 Billion KRW	-84.315%
Anterogen.Co.,Ltd.	9.74 Billion KRW	-744.708%
MEDIPOST Co., Ltd.	52.33 Billion KRW	-57.206%
CrystalGenomics, Inc.	32 Billion USD	-157.093%
Helixmith Co., Ltd	20.22 Billion KRW	-306.758%
Chabiotech Co.,Ltd.	449.63 Billion KRW	81.701%
Medy-Tox Inc.	82.83 Billion KRW	0.667%
Peptron, Inc.	9.13 Billion KRW	-800.888%
Amicogen, Inc.	149.59 Billion KRW	45.0%
Genexine, Inc.	67.42 Billion KRW	-22.025%
HLB Therapeutics Co.,Ltd.	10.02 Billion KRW	-720.945%
LegoChem Biosciences, Inc.	12.64 Billion KRW	-550.73%
ALTEOGEN Inc.	83.76 Billion KRW	1.78%
PharmaResearch Co., Ltd.	34.3 Billion KRW	-139.831%
SillaJen, Inc.	9.69 Billion KRW	-748.522%
JETEMA, Co., Ltd.	130.49 Billion KRW	36.95%
OliX Pharmaceuticals,Inc	39.35 Billion KRW	-109.054%
Genomictree Inc.	1.83 Billion KRW	-4384.648%
MedPacto, Inc.	8.6 Billion KRW	-856.263%
D&D Pharmatech	8.13 Billion KRW	-911.493%
GI Innovation, Inc.	3.72 Billion KRW	-2111.278%